Share This

Related Topics News -

     
 Title only   |   Print 
     
科笛-B無錫子公司獲江蘇省藥監局批出生產許可

2024-04-30T  
科笛-B治療脫髮產品於香港提交新藥上市申請

2024-04-30T  
《公司業績》科笛-B全年虧損擴至19.64億人幣

2024-03-27T  
科笛-B治療皮炎新藥臨床試驗申請獲內地受理

2024-03-27T  
科笛-B獲納入富時全球股票指數系列

2024-03-18T  
來凱、康龍化成、聖諾及藥明系急挫14%至21% 參院委員會通過生物安全法案

2024-03-07T  
藥明系急漲12%-22% 惟開拓及騰盛博藥挫15%-28%

2024-03-04T  
《異動股》科笛急吐18% 來凱續漲35%

2024-03-01T  
科笛-B料去年已商業化產品收入增逾11倍

2024-02-29T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.